Is mRNA technology the right fit for flu shots? Experts aren't so sure

Experts see some significant benefits of applying mRNA technology to the production of flu vaccine — but also some serious challenges.

Related Keywords

Michigan ,United States ,Hong Kong ,Raffael Nachbagauer ,Michael Osterholm ,Arnold Monto ,Sanofi Pasteur ,Florian Krammer ,Scott Hensley ,Norman Baylor ,Ben Cowling ,Barney Graham ,Kathleen Neuzil ,Astrazeneca ,Infectious Disease Research ,Hong Kong University School Of Public Health ,Morehouse University School Of Medicine ,Vaccine Development ,Pfizer ,Influenza Vaccine Initiative ,University Of Michigan School Public Health ,Centers For Disease ,University Of Pennsylvania Perelman School Medicine ,Global Health ,University Of Minnesota Center ,Drug Administration ,World Health Organization ,Advisory Committee On Immunization Practices ,Icahn School Of Medicine At Mount Sinai ,University Of Maryland School Medicine Center ,Northern Hemisphere ,Southern Hemisphere ,Icahn School ,Perelman School ,Morehouse University School ,Vaccine Graph ,Maryland School ,Disease Control ,Michigan School ,Hong Kong University ,Advisory Committee ,Immunization Practices ,